ID18079A - Komposisi farmasi yang mengandung bahan pemercepat osteogenesis - Google Patents

Komposisi farmasi yang mengandung bahan pemercepat osteogenesis

Info

Publication number
ID18079A
ID18079A IDP972959A ID972959A ID18079A ID 18079 A ID18079 A ID 18079A ID P972959 A IDP972959 A ID P972959A ID 972959 A ID972959 A ID 972959A ID 18079 A ID18079 A ID 18079A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical composition
osteogenesis
fastest
osteoporosis
derivative
Prior art date
Application number
IDP972959A
Other languages
English (en)
Indonesian (id)
Inventor
Tetsuo Hoshino
Kazuhiro Saito
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ID18079A publication Critical patent/ID18079A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDP972959A 1996-08-26 1997-08-25 Komposisi farmasi yang mengandung bahan pemercepat osteogenesis ID18079A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22344396 1996-08-26
JP9040897 1997-04-09

Publications (1)

Publication Number Publication Date
ID18079A true ID18079A (id) 1998-02-26

Family

ID=26431895

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972959A ID18079A (id) 1996-08-26 1997-08-25 Komposisi farmasi yang mengandung bahan pemercepat osteogenesis

Country Status (9)

Country Link
US (1) US6190695B1 (de)
EP (1) EP0949927B1 (de)
AT (1) ATE226078T1 (de)
AU (1) AU3868997A (de)
CA (1) CA2264131A1 (de)
DE (1) DE69716469T2 (de)
ES (1) ES2181017T3 (de)
ID (1) ID18079A (de)
WO (1) WO1998008517A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
AU4165699A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Composition for treating cartilage disease
EP1103552A4 (de) 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
AR020158A1 (es) * 1998-08-12 2002-04-10 Takeda Chemical Industries Ltd Mejorador del factor de induccion para la diferenciacion celular
CA2378486A1 (en) * 1999-08-05 2001-02-15 Takashi Kurasawa Osteogenesis promoter sustained-release paste
EP1293197A1 (de) * 2000-06-23 2003-03-19 Takeda Chemical Industries, Ltd. Prozess zur herstellung phospholipidhaltiger wirkstoffe
KR100799143B1 (ko) * 2001-01-19 2008-01-29 히로노리 야마모또 내시경용 주사제
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
US8158685B2 (en) * 2004-07-02 2012-04-17 Gregory Gene Steiner Method for bone growth
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
ES3047207T3 (en) * 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP2148685A4 (de) * 2007-04-25 2010-07-28 Cytochroma Inc Verfahren und verbindungen für die vitamin-d-therapie
CA2683628C (en) * 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DK656789A (da) 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd Benzoheterocykliske forbindelser
DK0460488T3 (da) * 1990-05-30 2001-09-17 Takeda Chemical Industries Ltd Svovlholdige heterocykliske forbindelser
AU6586394A (en) * 1993-04-22 1994-11-08 Celtrix Pharmaceuticals, Inc. Conjugates of growth factor and bone resorption inhibitor
JP3319625B2 (ja) * 1993-05-12 2002-09-03 ホーユー株式会社 速崩壊性生薬製剤
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
NZ308658A (en) * 1995-06-05 1999-10-28 Takeda Chemical Industries Ltd Sustained release synergistic pharmaceutical composition comprising a non-peptide osteogenetic promoting substance and a biodegradable polymer

Also Published As

Publication number Publication date
DE69716469T2 (de) 2003-02-20
AU3868997A (en) 1998-03-19
EP0949927B1 (de) 2002-10-16
WO1998008517A2 (en) 1998-03-05
CA2264131A1 (en) 1998-03-05
US6190695B1 (en) 2001-02-20
ES2181017T3 (es) 2003-02-16
DE69716469D1 (de) 2002-11-21
EP0949927A2 (de) 1999-10-20
ATE226078T1 (de) 2002-11-15
WO1998008517A3 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
SE9901272D0 (sv) New improved formulation
ATE136221T1 (de) Osteo-induktive pharmazeutische formulierungen
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
ATE382057T1 (de) Stabile formulierung von modifiziertem glp-1
GT199700009AA (es) Terapia combinada para la osteoporosis
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
MY118151A (en) Pharmaceutical formulations containing voriconazole.
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
SE9704186D0 (sv) New composition of matter
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
TR200101103T2 (tr) CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar
ATE212846T1 (de) Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
ATE395071T1 (de) Pharmazeutische zubereitungen zur angiogenese- therapie
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
ATE218364T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
BR0212857A (pt) Formulações e uso destas
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
WO2001030333A3 (en) Tissue factor antagonists and methods of use thereof
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
SE9802937D0 (sv) Novel compounds